Refractory Chronic Myelomonocytic Leukemia

Explore clinical trials studying Refractory Chronic Myelomonocytic Leukemia. Study availability and eligibility vary by location and protocol.

15 public trials 9 recruiting studies

Refine in advanced search Browse all conditions

Refractory Chronic Myelomonocytic Leukemia trial results

Completed

NCT01892371

Conditions: Bone Marrow Diseases, Chronic Disease, Disease Attributes, +20 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

Completed

NCT05030675

Conditions: Bone Marrow Diseases, Chronic Disease, Disease Attributes, +13 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

Completed

NCT03886831

Conditions: Adenocarcinoma, Adenoid Cystic Carcinoma, Anemia, +39 more
Locations: Banner MD Anderson Cancer Center Gilbert, Arizona, United States

UCSF Precision Cancer Medicine Building San Francisco, California, United States

Christiana Care Health Services, Christiana Hospital Newark, Delaware, United States

Florida Cancer Specialists Lake Mary, Florida, United States

View all 23 locations

Active, Not Recruiting

NCT02530034

Conditions: Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Blast Crisis, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, +31 more
Locations: Augusta University Augusta, Georgia, United States

Montefiore Medical Center, Albert Einstein College of Medicine The Bronx, New York, United States

M D Anderson Cancer Center Houston, Texas, United States

Huntsman Cancer Institute Salt Lake City, Utah, United States

Active, Not Recruiting

NCT04891757

Conditions: Advanced Hematologic Malignancy, Bone Marrow Diseases, Chronic Disease, +19 more
Locations: City of Hope National Medical Center Duarte, California, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

Memorial Sloan Kettering Cancer Center New York, United States

Vanderbilt University Medical Center Nashville, Tennessee, United States